NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT IS FILED AND ONLY THROUGH AN INTERMEDIARY’S PLATFORM. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND. "RESERVING" SECURITIES IS SIMPLY AN INDICATION OF INTEREST.






*Data represents an average of hundreds of samples taken by the Company
WITH INDUSTRY LEADERS






Air Force
Approved for contract extension for Phase 2
Space Force
Pending extension of OTA contract
Neurpac & Neurpac SaaS Beta Release
Q2 2024
Current Contracts Extended/Pending
2025
Neurpac 1.0 Release
Q1 2025
PCM Expected Alpha Release
Anticipated Q3 2025
Neurpac 2.0 Release
Anticipated Q1 2026
An evolved Neurpac product featuring a rewrite of the core, making it modular in nature
PCM Expected Beta Release
Anticipated Q4 2025; Full
release projected for 2026
Neurcom Beta Release
Anticipated Q4 2025; Full release projected for 2026
*These timelines are forward-looking statements based on current expectations and are subject to risks, uncertainties and changes in business conditions, so actual launch dates may differ materially from those anticipated.

MARKET LEADERSHIP
FOR DISRUPTOR TECHNOLOGY
“Disruptor Company”


“Technology Innovation”

“Data Transformation
Solution of the Year”


INVESTORS BACKING ATOMBEAM